News

French biotech ImCheck Therapeutics has announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its lead program, ICT01, a humanized anti-butyrophilin 3A (BTN3A ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...
However, the European Medicines Agency (EMA), against all odds, has refused to authorize its marketing. After almost two years of trying to get the agency to see reason, PharmaMar sued the ...
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second dose.
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...
European Medicines Agency Warns of Diabetics’ Risk Amid Ozempic Shortage Some doctors have been prescribing Ozempic for weight loss Use as slimming treatment may endanger diabetics, EMA says ...
The European Medicines Agency (EMA) has finally joined the discussion on artificial intelligence (AI) and machine learning (ML), releasing a draft reflection paper on the use of these ...